Karyopharm grants 1,850 RSUs to two newly hired employees
Karyopharm Therapeutics Inc. announced it granted an aggregate of 1,850 restricted stock units (RSUs) to two newly-hired employees under Nasdaq Listing Rule 5635(c)(4).
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.